Publication | Closed Access

Novel albendazole formulations given during the intestinal phase of Trichinella spiralis infection reduce effectively parasitic muscle burden in mice

Antiparasitic AgentMedicineParasitic ProtozoaTrichinella Spiralis InfectionParasitic Muscle BurdenNovel Albendazole FormulationsMicrobiologyHelminth InfectionPharmacologyAntimicrobial ResistanceParasitologyDrug Resistance